Squarepoint’s SOPHiA GENETICS SOPH Stock Holding History

Squarepoint’s Portfolio SOPH Stock Details SOPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.64M	Buy	+195,696	New	+$1.41M	﹤0.01%	2358
2025 Q4	–	Sell	-10,231	Closed	-$48.7K	–	4848
2025 Q3	$48.7K	Buy	+10,231	New	+$35.2K	﹤0.01%	4231
2025 Q1	–	Sell	-13,753	Closed	-$42.9K	–	5352
2024 Q4	$42.9K	Sell	13,753 -5,886	-30%	-$20K	﹤0.01%	4869
2024 Q3	$71.4K	Buy	+19,639	New	+$79.8K	﹤0.01%	3940
2021 Q4	–	Sell	-23,969	Closed	-$420K	–	3496
2021 Q3	$420K	Buy	+23,969	New	+$422K	﹤0.01%	2062

Other funds holding SOPH

Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return

Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $992M AUM 516.32% 1-Year Est. Return

Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Sowell Financial Services North Little Rock, Arkansas $3.12B AUM 22.73% 1-Year Est. Return

Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.31B AUM 25.55% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Squarepoint's SOPH Position: Q3 2026 in Review

Squarepoint opened a new position in SOPHiA GENETICS (SOPH) in Q3 2026: 195,696 shares worth $1.64M. The stake represents ﹤0.01% of the portfolio and ranks #2358 among its holdings. This is a return to the name: Squarepoint previously reported a position in SOPH as recently as Q3 2025.

Squarepoint first reported a position in SOPH in Q3 2021 and has held it in 5 quarters since. 27 funds tracked by Wall St. Rank hold SOPH as of Q3 2026.

Squarepoint held 195,696 shares of SOPHiA GENETICS worth $1.64M as of Q3 2026.
SOPHiA GENETICS was a new Squarepoint position in Q3 2026.
SOPHiA GENETICS made up ﹤0.01% of Squarepoint's portfolio in Q3 2026, its #2358 holding.
Squarepoint first reported a position in SOPHiA GENETICS in Q3 2021 and has held it in 5 quarters since.
27 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q3 2026.

Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.